Di Nuzzo Private Wealth, Inc. Bridge Bio Pharma, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $579 Million
- Q2 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 22 shares of BBIO stock, worth $563. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22
Previous 14
57.14%
Holding current value
$563
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BBIO
# of Institutions
292Shares Held
175MCall Options Held
8.66MPut Options Held
2.76M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$796 Million45.4% of portfolio
-
Viking Global Investors LP25.1MShares$644 Million2.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$360 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$319 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$156 Million67.33% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.8B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...